Purchase Price: ₹63000 - ₹70560
The Resmed Lumis 150 VPAP ST APAC with humidifier is a non-invasive ventilator for patients experiencing breathing difficulties. This device is indicated for non-invasive ventilation in patients weighing over 13 kg (or over 30 kg in iVAPS mode) with respiratory insufficiency or obstructive sleep apnea (OSA). The Lumis 150 VPAP ST is suitable for use in home and hospital settings, providing adequate respiratory support for needy patients.
At Portea, we offer rental and sale services for the Lumis 150 non-invasive ventilator, providing equipment and support to patients who rely on this device. Our team can assist you in selecting the most suitable product and administration range to meet your specific needs.
The Lumis 150 VPAP ST-A is a non-intrusive ventilator equipped with alarms. It is designed for patients with respiratory insufficiency who do not depend on invasive ventilation. This ventilator maintains ventilation at the alveoli level, adjusting to the patient’s changing requirements.
With its unique volume assurance mode called iVAPS (intelligent volume-Assured Pressure Support) and intelligent Backup Rate (iBR) and AutoEPAP options, the Lumis 150 continuously monitors ventilation and the upper airway. This advanced technology ensures optimal support and ventilation management for patients.
Category: Bi-Level PAPs / Non-Invasive Ventilators
Brand: ResMed
The Lumis TX is a versatile non-invasive ventilator designed to treat a wide range of respiratory conditions effectively. It is suitable for use in various hospital environments. It offers a quick and convenient solution for treating patients with pre-diagnosed obstructive sleep apnea (OSA) who are admitted for other medical conditions or surgeries. The Lumis TX provides comprehensive respiratory support and is designed to meet the diverse needs of patients in a hospital setting.
The main difference between oxygen therapy and ventilation lies in the level of support provided to the patient’s respiratory system. Oxygen therapy simply involves administering supplemental oxygen to the patient while the lungs continue to inhale oxygen-rich air and exhale carbon dioxide. On the other hand, a ventilator not only delivers additional oxygen but also assists the patient’s breathing by taking over the work of the lungs, effectively performing both inhalation and exhalation on behalf of the patient. Ventilation provides more comprehensive respiratory support compared to oxygen therapy.
The normal oxygen level on a ventilator, specifically for adults with COVID-19 receiving supplemental oxygen, needs to be precisely defined. However, a target oxygen saturation level (SpO2) of 92% to 96% is reasonable. While exact thresholds may vary, maintaining SpO2 within this range is generally recommended, as evidence suggests that levels below 92% or above 96% could potentially have adverse effects. It is important to consult with healthcare professionals who can assess each patient’s specific needs and adjust the oxygen levels accordingly.
The choice between oxygen therapy and a ventilator depends on the individual’s respiratory needs. An oxygen concentrator is beneficial for individuals with low oxygen levels, as it provides a higher oxygen concentration to supplement their breathing. In contrast, a ventilator is used when a patient requires assistance with respiration, taking over the work of breathing to provide rest and support while the body heals. The decision on which is better depends on the severity and underlying cause of the respiratory condition and is best determined by medical professionals based on the patient’s needs.
Doctor Consultation
Nursing
Physiotherapy
Trained Attendant
Elder Care
Mother & Baby Care
Lab Tests
Medical Equipment
Speciality Pharma
Critical Care